arrow
I

Imperia Nuzzolese

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:7
被引数:232

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center

液态活检用于评估和监测间变性甲状腺癌中的BRAF V600E:一项三级癌症中心的真实世界研究

2026-06-230
OAAI
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study

分子检测和精准肿瘤学对晚期甲状腺癌患者的影响:一项OrienTHYring真实世界研究

2025-10-290
OAAI
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management

伦伐替尼在晚期甲状腺癌、唾液腺癌、子宫内膜癌和肝细胞癌中的应用:一项关于治疗持续时间与毒性管理的真实世界研究

2025-09-120
OA
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study.

头颈部鳞状细胞癌患者临终期系统性抗肿瘤治疗。一项回顾性单中心研究。

2025-08-290
OAAI
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study

非流行区EBV相关鼻咽癌(NPC)血浆EBV-DNA的纵向评估:LEA研究

2025-07-090
PRE
Tyrosine kinase inhibitors-induced erythrocytosis in thyroid cancers: A novel safety signal from a retrospective study

酪氨酸激酶抑制剂诱导的甲状腺癌红细胞增多症:一项回顾性研究中的新安全信号

2024-09-010
PRE
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience
2023-11-014
OAAI